Rocket RKT 深 沪
等待开盘 08-10 09:30:00 美东时间
13.75
+0.520
+3.93%
华盛通- 最 高14.39
- 今 开14.24
- 成交量 3918.41万股
- 最 低 13.015
- 昨 收 13.23
- 总市值 163.63万
- 52周最高 24.36
- 市盈率 静 5.92
- 换手率 32927.79%
- 52周最低 12.17
- 委 比 61.06%
- 总股本 0.00亿
- 历史最高 40.88
- 量 比 1.60
- 振 幅 10.39%
- 历史最低 5.97
- 每 手 1
- 风险率 2.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Axe Compute Secures $1.5 Billion AI Deal Powered by Nvidia
Axe Compute secures a five-year AI infrastructure contract worth over $1.5 billion, deploying more than 9,200 NVIDIA Blackwell B300 GPUs in the U.S.
07-28 00:40
Why Is L3Harris Stock Gaining Monday?
LHX stock gains after L3Harris signs framework agreements to expand THAAD and PAC-3 missile defense propulsion production.
07-27 23:53
Rocket Lab Secures Biggest Launch Deal Yet as Space Demand Grows
Rocket Lab shares rise after securing a record $266 million U.S. Space Force contract for 12 suborbital launches through 2028.
07-27 19:47
Rocket Lab Awarded $266M Multi-Launch Contract By The U.S. Space Force
This landmark contract further solidifies Rocket Lab’s position as a leader in launch and critical mission enabler for programs with significant national importance.Under the contract awarded by the U.S. Space Force
07-27 18:01
Rocket Lab Stock Has Plunged 60% From YTD High
Rocket Lab stock price has plunged in the past few weeks as space companies continued falling. Is it a good buy today?
07-27 04:27
Benzinga Bulls and Bears: IBM, Super Micro, Tesla
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
07-25 20:00
SpaceX Stock Sits Below IPO Price: What's Happening Today?
Space Exploration Technologies shares are slipping Friday. HSBC initiated coverage with a Hold rating and a price target below the IPO price.
07-24 22:11
SpaceX Stock’s Hidden Risk Isn’t Rockets — It’s AI Spending
SpaceX stock faces risks as Starship reaches launchpad, but the bigger threat may be AI spending.
07-24 00:08
Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates
Curis shares positive updated clinical data for emavusertib and increases its year-end guidance for the TakeAim CLL study.
07-23 01:04
Market-Moving News for July 22nd
RKLB: 8% | Rocket Lab shares are trading higher after the company announced it was awarded a $266 million firm-fixed-price completion contract for suborbital launch. SMCI: 20% | Super Micro Computer Reports Preliminary
07-22 19:18
